The Induction of Mammary Carcinoma in the Rat * by Nelson, Warren O.
THE INDUCTION OF MAMMARY CARCINOMA IN
THE RAT*
WARREN 0. NELSON
Evidence that intrinsic endocrine factors exert an influence on
mammary carcinogenesis was reported first by Lathrop and Loeb"3
and confirmed by Cori,2 Murray"5, de Jongh and Korteweg,10 and
others. These reports, which dealt with spontaneous cancer as
influenced by ovariectomy and ovarian transplantation, received fur-
ther confirmation and extension in the studies of Lacassagne,11' 12
Burrows and Kennaway,' Cramer and Horning,3 and Gardner,
Smith, Allen, and Strong.5 These investigators showed that estro-
genic hormone isthe most important ovarian influence in carcinogene-
sis and that increase in the incidence of tumors can be induced in
cancer-susceptible strains of mice. Excellent, reviews of the litera-
ture bearing on this subject have been written by Gardner4 and by
Greene and Brewer.9
Although the evidence for a relation of estrogen to the occur-
rence of mammary carcinoma in the mouse is convincing, the results
of studies in other species have been largely negative (Greene and
Brewer9). The exceptions are reports by McEuen,14 Geschickter6 '
and Geschickter and Byrnes8 on the induction ofmammary carcinoma
in the rat by prolonged treatment with estrogen. The incidence of
malignant growths in the rat has been lower than in cancer-suscept-
ible mice and, indeed, some workers have reported completely nega-
tive results. However, it is likely that such findings merely reflect
the fact that the strains of rats which have been studied lack the
genetic background for mammary carcinoma. In the mouse a high
degree of selection has served to segregate pure lines, some of which
exhibit a singular tendency to develop certain forms of neoplastic
disease.
Geschickter' 7 and Geschickter and Byrnes8 have been able to
induce mammary carcinoma in rats with some degree of regularity
(202 cases reported). They believed that the type of neoplasia can
be controlled by the procedure employed. Thus, they report that
the mammary glands of animals which had been injected daily with
one or another of the estrogenic substances showed hyperplasia, cyst
formation, adenosis, papilloma, and cancer in that chronological
sequence. The process occurred only when the dose was above
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physiologic levels and it was accelerated, within certain limits, when
the dose was increased. Essentially the same results were obtained
when animals were implanted with pellets of estrogen, a method
which provides a greater constancy of hormonal action, except that
fibroadenomas were more prone to occur prior to the appearance of
carcinoma. Injections were more likely to produce duct carcinoma,
particularly if ovariectomized rats were used, while pellets fre-
quently induced infiltrating lobular cancer.
In the course ofstudies during the past five years on the develop-
ment of adenomas of the hypophysis in the rat numerous tumors of
the mammary glands have been o'bserved. This led us to give the
question of mammary carcinoma further attention and finally to
assemble the data which had been collected during the earlier
observations.
Procedures
The studies reported at this time include observations upon three groups
of rats. The animals in Group I (127 rats) received daily injections of 50
micrograms of diethylstilbestrol for periods ranging from 70 to 600 days. In
Group II (29 rats) treatment consisted of the implantation of one to four 10
mg.-pellets of diethylstilbestrol, with observations ranging from 60 to 420
days. The rats in Group III (53 animals) received three to six 10 mg.-
pellets of estrone and were observed for 60 to 500 days. Treatment was
begun in all groups at ages ranging from 60 to 80 days. Both males and
females were included in these groups and none was gonadectomized. These
rats were derived from the Long-Evans hooded strain, and over a period of
15 years no spontaneous mammary tumors, with the exception of 4 fibro-
adenomas, have been observed. One of these appeared in a female of a series
of controls studied in parallel with this experiment. Routine laboratory care,
including main-tenance on Rockland Rat Ration and occasional greens, was
given these animals.
Body weights and observations were taken routinely and the general con-
dition of the animals was noted. When tumors appeared, usually detected
initially as small nodular lumps, they were recorded and cobserved for further
growth. The animals observed for the shorter periods were sacrificed at the
desired intervals. In the case of more prolonged observations (more than 150
days) complications frequently arose and necessitated termination of the indi-
vidual experiment, either through death of the animal or because its weakened
condition indicated that death was imminent. These complications included
pyometra, adenomas of the hypophysis in both sexes, and, less frequently, dis-
orders of the urinary organs and respiratory infections.
At autopsy all mammary glands were observed and if any neoplasia was
detected the lymph nodes and lungs were examined. In addition to samples
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of these all endocrine organs, representative portions of the reproductive tract
and portions of the kidneys and liver were taken routinely for fixation and
study. If autopsy revealed any unusual condition in other organs they were
preserved. Fixation was carried out with either Bouin's fluid or Zenker-
formol and various staining procedures were followed, of which Masson's
trichrome method and hematoxylin and eosin were routine.
Results
Group I. In animals which received 50 micrograms of diethyl-
stilbestrol daily mammary changes ranging from simple hyperplasia,
cystic hyperplasia and hypertrophy, and fibrosis to metaplasia, early
duct carcinoma, advanced duct carcinoma, adenocarcinoma, and car-
cinoma simplex were observed. The several conditions of the mam-
mary glands depended in part upon the length of the experiments,
but the nature of the treatment appeared to emphasize the likelihood
of the development of duct carcinoma in animals which lived more
than 400 days after the initiation of injections.
Since no marked pathological change appeared in the mammary
glands earlier than the 300th day of treatment, the animals which
died or were sacrificed prior to this time will be considered together.
Included in this sub-group are 73 of the 127 rats. In these the
earliest evident effects of treatment included the usual extension
of the duct system, proliferation of terminal buds, and early estab-
lishment of a lobular pattern. This effect appeared earlier in
females, 'but a sexual difference was not readily apparent with longer
treatment After injections had continued for about 130 days the
glands usually presented the appearance of small and large cysts
filled with a coagulated or inspissated secretion. This condition
frequentlywas attained earlier, but was present uniformly before the
end of the fifth month of treatment. The cysts appeared in the ter-
minal ducts and the acini and, as the products of secretion accumu-
lated, distension of the larger ducts occurred. Concomitant with or
closely following the development of cysts the periductal and peri-
acinar connective tissue increased in amount and density (Fig. 1).
This fibrosis was progressive throughout the period of cyst formation
and during the more advanced stages of neoplasia.
Of the 54 animals which lived more than 300 days 39 were
males. The frequent occurrence of pyometra reduced the number
of females that survived. continued treatment. However, no sig-
nificant difference has been observed between males and females in
the development of metaplastic and neoplastic changes in the breast
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and no distinction will be made between the sexes in the following
discussion.
Ten animals in which treatment continued for from 480 to 600
days showed no pathological change of the mammary glands beyond
cystic disease and fibrosis. Seven of these animals were sacrificed
or died because of hypophysial tumors, one succumbed to pneumonia,
and two became so severely cachectic that they were sacrificed.
Autopsyindicated that chronic glomerular nephritis was the probable
cause of their decline.
Eleven animals that died or were sacrificed 'between the 300th
and 500th days of treatment showed metaplasia of the mammary
parenchyma (Fig. 1). This was evident principally in the smaller
ducts and usually was seen in glands which also contained cysts. In
some instances one or more of the glands showed appreciable thick-
ening of the ductal epithelium with small papillomatous growths
while other glands in the same animals showed cysts only. It seems
probable that metaplastic change is a forerunner of duct carcinoma,
since it has been seen frequently in conjuncti6n with the latter con-
dition. Geschickter and Byrnes have expressed the opinion that the
appearance of carcinoma is delayed when cysts form, since these
must degenerate and atrophy before cancer can develop. Although
this idea is probably correct it should be noted that such change is,
primarily at least, a purely local transformation, since cysts, meta-
plasia and carcinoma may be seen co-existing in the same gland and,
indeed, in the same general area.
In general, it may be said that metaplastic change in the glands
of our animals marked the period between 300 and 400 days. The
parenchymatous metaplasia was accompanied uniformly by advancing
fibrosis which we believe is a constant forerunner of carcinoma in
these animals. This fibrosis frequently contributes to the develop-
ment of a condition which has been regarded as fibroadenoma by
Geschickter and Byrnes.
Twenty-eight animals which survived more than 300 days
showed some form of mammary carcinoma in one or more glands.
PLATE I
All illustrations are taken from the mammary glands of animals in Group I which had received
50 micrograms of stilbestrol daily by subcutaneous injection. Tissue fixed in Bouin's fluid, sec-
tioned at 8 microns, and stained by Masson's trichrome method. x100.
FIG. 1. Cysts, fibrosis, and early metaplasia.
FIG. 2. Early duct carcinoma. One duct shows small papillomatous growths, others cysts,
and metaplasia.
FIG. 3. Advanced duct carcinoma. Some infiltration has begun.
FIG. 4. Adenocarcinoma (lobular carcinoma).
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In 10 animals, ranging from 400 to 560 days, the tumor was diag-
nosed asearlyduct carcinoma (Fig. 2). In many regions of the can-
cerous glands, and in glands not involved by cancer, metaplasia and
cystic disease were present. Without exception the existence of a
carcinoma was accompanied by further increases in the density and
quantity of stroma. In two animals regional lymph nodes showed
metastatic foci.
In 11 of the remaining animals treatment was continued until
termination of the individual experiment (500 to 600 days). Each
of these rats showed advanced carcinoma and in 5 instances the
cancers were regarded as the cause of death. Six animals showed
duct carcinoma only (Fig. 3), 3 had adenocarcinoma (Fig. 4), in
one both duct and adenocarcinoma were present in different glands,
and one showed a variety ofpictures in the several glands, two glands
with carcinoma of ducts and acini, one with carcinoma simplex (Fig.
5), and one with co-existing adenofibroma and adenocarcinoma. In
this sub-group metastases to the regional lymph nodes (Fig. 6) were
seen in the 4 cases of adenocarcinoma and in 3 of these the lungs also
showed metastatic foci. Metastases to lymph nodes were seen in
3 of the animals with duct carcinoma (Fig. 7). In the rat with
multiple tumors one metastatic focus, apparently of the carcinoma
simplex, was seen in a lymph node.
In 12 animals treatment was suspended at the end of 400 days.
This was done to observe the occurrence of neoplasia in the absence
of further estrogenic activity. Treatment was stopped at the 400th
day, since the earliest cases of carcinoma appeared at about that time.
Three of the animals showed very small palpable nodules which on
biopsy proved to be early duct carcinoma. Most of the animals pre-
sented symptoms of hypiophysial tumor when treatment was discon-
tinued. However, in each instance these symptoms disappeared and,
as revealed at autopsy, the hypophysial tumors underwent involu-
tion. In the animals which were examined six or more months later
the hypophyses had returned to a size only slightly above normal.
Four animals were sacrificed at from 60 to 75 days after treat-
ment was suspended. The breasts of 2 of these showed cysts and
metaplasia only, and in 1 anilmal cysts, metaplasia, and intraductal
papillomatous growths showing numerous mitoses were present.
PLATE II
FIG. 5. Cacinoma simplex.
FIG. 6. Adenocarcinoma; metastatic growth in a lymph node.
FIG. 7. Duct carcinoma; metastatic growth in a lymph node.
FIG. 8. Adenocarcinomna; relatively early.
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The fourth rat showed cysts and metaplasia in all glands except one
inguinal gland which had grown very rapidly during the course of
three weeks and which upon section presented the picture of car-
cinoma simplex.
Four animals died or were sacrificed 170 to 185 days after cessa-
tion of treatment. Three of these showed duct carcinoma, with
metastases to regional lymph nodes in one instance. The fourth
animal showed no mammary pathological changes beyond a few per-
sistent cysts and a minor degree of metaplasia.
Four animals died or were sacrificed from 240 to 270 days after
treatment had been suspended. This group included the 3 animals
which had shown small nodular growth. In each of the 4 cases
duct carcinoma was present in several glands. Two animals showed
metastatic foci in the regional lymph nodes and in the remaining
2 both lungs and lymph nodes contained metastases.
The results in the animals included in Group I are summarized
in table 1.
TABLE 1
SUMMARY OF ALL ANIMALS ON TREATMENT WITH ESTROGENS
Extent of Early
treatment No. of Cysts & Meta- duct
(days) animals fibrosis plasia Ca.
Advanced Duct &
duct Adeno- Adeno- Ca. Metas-
Ca. Ca. Ca. simplex tases
Group I. Animals on daily injections of diethylstilbestrol (50 micrograms)
10 73 32 .... .... .... .... .... ....
10 42 10 11 10 6 3 1 1
Animals on daily injections of diethylstilbestrol (50 micrograms)
for 330 days. No treatment thereafter. Figures in "treatment"
column indicate time after cessation of injections.
5 4 3 .... .... .... .... .... 1
15 41 .... ... 3 ... .... ....
4
10
8
11
7
8
11
32
4 .... ....
Group II. Animals with pellets of diethylstilbestrol
6 .... .... ... .... ....
2 6 .... .... .... ....
.... 3 .... 7 .... 1
Group III. Animals with pellets of estrone
7 .... .... .... .... ....
2 4 1 .... .... ....
3 4 4 .... .... ....
4 3 5 5 5 8 2 18
8
0-30
330-60
60-75
170-18
240-270
0-200
200-250
270-420
60-120
130-200
200-300
300-500
4
.... ....
.... 2
. .
i..
....
I
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Group II. The animals in this group received from one to four
10 mg.-pellets of diethylstilbestrol implanted subcutaneously. In
each rat the pellets were implanted singly at intervals of 3 to 4
months. The general trend of effects was similar to that seen in
the animals of Group I where stilbestrol in oil hadbeen administered
by injection, except that the entire process was accelerated. Thus,
the earliest instances of carcinoma occurred in this group at 250 days
as compared with 400 days in Group I.
Ten animals died or were sacrificed before the 200th day of
treatment. In these, the mammary glands showed marked develop-
ment of the ducts and acini with the appearance of cysts and fibrosis
in animals sacrificed afterthe 70th day. It is noteworthy that larger
numbers of small cysts were present than in the animals of Group I.
This finding may reflect the fact that the glands of animals which
received stilbestrol by pellet underwent better development of acini
with subsequent cystic dilatation.
Eight animals died or were sacrificed between the 200th and
250th days of treatment. In 6 of these metaplastic changes in the
ducts were evident. The other 2 showed cystic disease only.
Of the 11 animals which survived from 270 to 420 days 8
showed carcinoma. In 7 ofthese 'the ducts only were involved while
a single animal showed multiple growths, some of which contained
adenocarcinoma. In one of the animals whose glands showed duct
carcinoma only, one of the breasts contained areas which were
regarded as intercanalicular adenofibroma. In 2 instances metastatic
foci were found in regional lymph nodes. The three rats in which
carcinoma was not found showed cysts, fibrosis, and metaplasia only.
These rats were autopsied at from 350 to 420 days after the initial
implantation and probably represent that group of animals whose
glands are resistant to the development of carcinoma. In one
instance a massive fibroma was present on the right forelimb. This
growth involved the dorsal aspect of the upper limb, invading the
extensor muscles, but not involving in any way the adjacent mam-
mary gland.
The findings in this group are summarized in table 1.
Group III. The animals in this group received 10 mg.-pellets
of estrone (theelin) implanted under the skin of the back. As a rule
2 pellets were implanted initially with an additional implantation
every 2 to 4 months. Most of the animals which lived more than
12 months received 6 pellets.
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Seven rats were sacrificed between the 60th and 120th days of
treatment. In each of these a marked cystic condition and an asso-
ciated fibrosis were present.
Eight animals were sacrificed or died between the 130 and 200th
days: In 2 of these, cysts and fibrosis only were present, 4 showed
various degrees of metaplasia as well, and 2, both sacrificed at 150
days, had glands which contained carcinomas. In one of these the
condition was early duct cancer, while in the second a massive undif-
ferentiated adenocarcinoma (simplex) was present in one anterior
gland. This growth had been noted for the first time less than three
weeks before the animal was sacrificed and it had grown very rapidly,
weighing 54 grams at autopsy. Metastases were present in the axil-
lary and mediastinal lymph nodes.
Eleven animals died or were sacrificed between the 200th and
300th days. In 3 instances cysts and fibrosis only were found, 4
animals showed metaplastic changes in addition, and 4 showed early
carcinoma. In one ofthese, the ducts and acini were involved, while
duct cancer only was present in the remaining 3. No metastases
were found.
The remaining 32 animals in this group continued on treatment
for periods ranging from 300 to 500 days. In 4 instances, including
2 animals which lived to the 500th day, cysts and fibrosis only were
present. Three animals, all living approximately 400 days, showed
metaplasia as well as cysts and fibrosis.
In 5 animals early carcinoma was found. The glands of 2 of
these showed involvement of both acini and ducts while in 3 duct
carcinoma only was present. No metastases were found.
Twenty animals showed tumors that were regarded as advanced
carcinoma. In 4 of these duct cancer was present, 2 showing metas-
tases to lymph nodes, and 1 metastases to lymph nodes and lungs.
In 5 animals the tumors were diagnosed as adenocarcinoma with
metastases to lymph nodes in 3, and to both lymph nodes and lungs
in 2 instances. Eight animals showed multiple tumors some of
which, in each rat, were duct carcinoma and others adenocarcinoma.
In 4 of these metatastic foci were found in regional lymph nodes, in
3 both lungs and lymph nodes showed metastases, and 1 animal
appeared to be free from secondary growths. Two rats had tumors
which were regarded as carcinoma simplex. As in the other instances
where this type of cancer was seen the tumors grew very rapidly.
In each case extensive metastases were seen in the regional lymph
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nodes. A single animal showed duct carcinoma with extensive intra-
ductal papillomatous growths and metastases to regional lymph
nodes.
The results of observations on animals of Group III are sum-
marized in table 1. It may be said that carcinoma appears to have
developed more rapidly in the animals of this'group than in those
which received diethylstilbestrol. Cysts and fibrosis occurred as
early as the 60th day, metaplasia by the 130th day, and carcinoma by
the 150th day of treatment. The latter figure represents extreme
instances, but it seems likely that in most of the animals which
developed cancer the growths appeared before the 250th day.
While duct carcinoma was the dominant type seen in animals treated
with stilbestrol, adenocarcinoma was at least as common in animals
which received pellets of estrone.
Discussion
Simplicity was regarded as desirable in the classification of the
various cancers seen in this study. Thus, growths which appeared
to involve ducts only and which usually were well circumscribed
were diagnosed as duct carcinoma and were subdivided only into
early (Fig. 2) and advanced (Fig. 3) stages on the basis of the
number and the size of the intraductal growths. All instances in
which the process appeared to involve terminal tubules and acini
and in which the tumor maintained some measure of a lobular pat-
tern have been classified as lobular or adenocarcinoma (Figs. 4
and 8). Some of these have shown a greater degree of infiltration
than have others and on some bases of classification they would have
been graded accordingly. Finally, those cancers in which the entire
lo;bular pattern was destroyed and in which the cells were small,
highly anaplastic, and tightly packed were regarded as carcinoma
simplex or undifferentiated carcinoma (Fig. 5). The metastatic
growths have tended to follow the pattern seen in the primary
tumor (Figs. 6 and 7).
Although certain differences appeared in the rate of tumor for-
mation in the several groups, the fundamental process appears to
have been similar throughout. In all likelihood such differences as
existed can probably be accounted for on the basis of variations in
the, effective levels of estrogen. Thus, pellets of diethylstilbestrol
or of estrone produced a more rapid sequence of mammary changes
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than did daily injections of diethylstilbestrol, because effective levels
of estrogen were maintained in a more constant fashion. The fur-
ther acceleration seen in animals with pellets of estrone as compared
to those with pellets of diethylstilbestrol may not be significant,
since the number of animals in the latter series was relatively small.
Furthermore, Geschickter and Byrnes8 observed no such difference
in their more extensive examination of various estrogens. How-
ever, the more frequent occurrence of adenocarcinoma in animals
which received pellets of estrone would indicate that estrone may
have had a more marked effect than diethylstilbestrol on the acini.
In general, the observations which have been made in this study
on animals derived from the Long-Evans hooded strain confirm the
findings of Geschickter and Byrnes,8 who used a strain of albino
rats. It should be noted that Noble, McEuen and Collip'" reported
studies on black hooded rats ofunknown geneticbackground in which
they observed the occurrence of mammary tumors following the
implantation of pellets of estrone. Although they were unwilling
to classify these tumors as cancer, some of their illustrations indicate
that certain of their rats, at least, had developed duct carcinoma.
The differences between the observations reported here and those of
Geschickter and Byrnes may be due, in part at least, to variations
in responses shown by different strains of animals. Thus, the whole
process seems to have been more rapid in their rats and in some cases
they reported carcinoma at very early stages of treatment (21 to 90
days). Nothing approaching this rapidity was observed in our ani-
mals where it seems likely that the entire sequence of hyperplasia,
cystic dilatation, fibrosis, and metaplasia preceded the appearance of
anaplasia and cancer in each instance.
The more frequent occurrence of metastases of carcinoma sim-
plex and of adenocarcinoma, both of which showed more marked
tendencies toward infiltration than any of the duct carcinomas, was
not surprising (see table 2). The very rapid growth shown by
tumors which proved to be carcinoma simplex was remarkable. Even
in those tumors which were studied within three weeks after they
were first noted the complete lack of organization of the-parenchyma
was striking. The small, tightly packed, highly anaplastic epithelial
cells and the relative scarcity of well-defined stromal elements gave
the superficial appearance of a sarcoma.
It is of interest to note the co-existence of mammary neoplasia
and chromophobic adenomas of the hypophysis. This was true in
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TABLE 2
SUMMARY OF TYPES OF CARCINOMA AND METASTASES
No. in which
No. of metastases Percentage of rats
tumors occurred with metastases
Duct carcinoma ........................... 4213 31
Adeno-carcinoma ........................... 88 100
Duct and adeno-carcinoma .................. 13 8 62
Carcinoma simplex5........................54 80
every instance except for the animals of Group I in which the injec-
tions were discontinued. Although the observations on this latter
series indicate that the altered endocrine relations which attend such
tumors probably are not responsible for the full realization of neo-
plasia in the breast, they throw no light upon the factors responsible
for the early stages of the process. The observations on this group
of animals do indicate that continued treatment with estrogen is not
essential for the complete development of carcinoma. In three of
the animals biopsies taken at the time treatment was suspended
showed early duct carcinoma. These tumors continued to develop
during the subsequent period when no injections were given. In
others, which went on to develop cancers, no tumors were detected
at the cessation of treatment, although it cannot be asserted that the
final stages ofthe process were not established. In this regard one is
reminded of Cori's studies,2 in which the time ofcastration in cancer-
susceptible mice played a governing role in the occurrence of mam-
mary carcinoma.
If the various groups are examined for the incidence of cancer
and those animals which survived treatment for at least 300 days or
which developed cancer before that time are assembled it is seen that
in Group I 29 of 54 animals (54 per cent) showed mammary car-
cinoma. In Group II 8 of 11 animals (73 per cent) and in Group
III 31 of 38 animals (82 per cent) developed cancer. For all
groups the figures are 68 of 103 animals (66 per cent). Although
some of those rats which were negative when autopsied might have
developed cancer if they had been able to continue on treatment,
it is likely that most of them were resistant to the final stages of the
neoplastic process.
Although no distinction has been made between the sexes in the
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account of these observations it may be noted that in the develop-
ment of mammary carcinoma no significant difference could be
detected between males and females, none of which was gonadec-
tomized.
Summary
The administration of estrogenic substances by injection or by
implantation of pellets in rats induced the appearance of mammary
carcinoma in 68 of 103 animals which survived treatment long
enough to permit the development of cancer (at least 300 days). It
seems probable that some animals are resistant to the final stages of
the neoplastic process which leads to the development of mammary
carcinoma.
The various cases were distributed through several types of car-
cinoma. Duct carcnoma, 42 rats; adenocarcinoma, 8 rats; mixed
duct andadenocarcinoma, 13 rats; carcinoma simplex, 5 rats. Meta-
stases to lymph nodes or to lymph nodes and lungs were observed in
33 animals.
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